Search

Author/Creator Edwards, C.

71. SAT0389 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from the Palace 4 Phase 3, Randomized, Controlled Trial. (10th June 2014)

Authors:
Edwards, C.; Wells, A.; Adebajo, A.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Stevens, R.M.; Aelion, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
735
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

72. SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials. (10th June 2014)

Authors:
Mease, P.J.; Kavanaugh, A.; Gladman, D.; Adebajo, A.O.; Gomez-Reino, J.J.; Wollenhaupt, J.; Cutolo, M.; Schett, G.; Lespessailles, E.; Shah, K.; Hu, C.; Stevens, R.; Edwards, C.; Birbara, C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
742
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

73. SAT0562 Long-Term (104-Week) Efficacy and Safety of Apremilast Monotherapy in Dmard-Naïve Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (Palace 4). (9th June 2015)

Authors:
Wells, A.; Edwards, C.; Adebajo, A.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Aelion, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
863
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗